Home Allium Medical

Allium Medical

    Allium Medical Receives CFDA Clearance to Market its Minimally-invasive BPH Implant and Premium Urological Stents in China

    5/14/18: "Gaining CFDA clearance is an important milestone as we strive to grow our APAC business. With our unique portfolio of minimally invasive urological systems, and in view of the above factors, we believe we are strongly positioned to achieve this objective," said CEO Asaf Alperovitz.

    RECENT COMMENTS